SEP-4199

N/A

Report date: 2026/02/27 20:01:47
NME

Base Information

Drug NameSEP-4199
Drug Alias Namenon-racemic amisulpride85:15 ratio of aramisulpride:esamisulpridearamisulpride:esamisulpride(85:15)SEP-4199
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 7 (5-HT7) receptor modulators
TargetsSerotonin 7 (5-HT7) receptor
Therapy Area/IndicationsBipolar I DisorderDepression
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBulgariaCanadaUnited States +[10] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesSunovion Pharmaceuticals IncOtsuka Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSumitomo Dainippon Pharma Co LtdOtsuka Pharmaceutical Co Ltd
Inactive CompaniesSumitomo Pharma America Inc
Active IndicationsDepression
Inactive IndicationsBipolar I Disorder

Other Information

ATC CodeN/A
Related LinksN/A